Maiken Keson-Brookes, CLO & Corporate Secretary at Rubius Therapeutics, Inc. (RUBY), sold 50,000 shares at $20.24 ($1.0M) on 2021-03-15, disclosed to the SEC on 2021-03-15.
Open-market sale of $1.0M RUBY by CLO & Corporate Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.24 | 25,000 | $506K | 50.0% |
| 2 | $20.24 | 25,000 | $506K | 50.0% |
| Total | $20.24 avg | 50,000 | $1.0M | 100% |
| Filing → |
| MURA | SELL | 2025-03-05 | $9K | — | Filing → |
| MURA | SELL | 2024-12-26 | $8K | — | Filing → |
| MURA | SELL | 2024-07-18 | $7K | — | Filing → |